Food and Drug Administration

Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…

WASHINGTON (AP) — U.S. health officials have expanded approval of a much-debated drug aimed at boosting female libido,…

Dec. 2 (UPI) — As a new blood tests capable of detecting dozens of cancers in their early…

MannKind If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) in under…

Shelby Knowles / Bloomberg / Getty Images Eli Lilly shares have added over a third of their value…

The largest American public health-care companies outperformed other industries in the third quarter, as higher new and specialty…

FDA requests, and Vanda agrees to, a brief extension (to December 5, 2025) for the expedited re-review of…

Don’t look now, but the costs of America’s beloved weight loss drugs are about to come down. Way…

European weight-loss drug developers have staged something of a comeback this week, as investors rotate into healthcare from…

While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis,…

US regulators laid out new guidelines for approving custom-made treatments for individual patients, a move that could bring…

The US Food and Drug Administration under a second Trump administration is mired in discord, acrimony and chaos…

Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)